A randomized, double-blind, placebo controlled, multicenter study of subcutaneous secukinumab, to demonstrate efficacy after twelve weeks of treatment and to assess safety, tolerability and long-term efficacy up to one year in subjects with moderate to severe chronic plaque-type psoriasis with or without psoriatic arthritis comorbidity (CAIN457A2318) | AVESİS

Manisa Celal Bayar Üniversitesi Akademik Veri Yönetim Sistemi

A randomized, double-blind, placebo controlled, multicenter study of subcutaneous secukinumab, to demonstrate efficacy after twelve weeks of treatment and to assess safety, tolerability and long-term efficacy up to one year in subjects with moderate to severe chronic plaque-type psoriasis with or without psoriatic arthritis comorbidity (CAIN457A2318)

BİLAÇ C., ŞAHİN M. T., ÖZTÜRKCAN S.

Diğer Uluslararası Fon Programları, 2017 - 2018

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Şubat 2017
Bitiş Tarihi: Kasım 2018